In May the Psychiatry Research Institute at Montefiore Einstein (PRIME) celebrated the opening of its new Einstein office in the Van Etten Building with a symposium and poster session highlighting its work in basic, translational, and clinical science.
Jonathan Alpert, M.D., Ph.D., professor and chair of psychiatry and behavioral sciences at Einstein and Montefiore, noted that the pandemic had brought home “the profound impact of mental health conditions and the need for new treatments and equitable access to care. If we’ve learned anything from the horrors of COVID-19, it’s the urgency of our institute’s mission to advance knowledge and treatment discovery related to mental illness, addiction, and behavioral health.”
He added: “PRIME lives within an academic medical center known for its commitment to rigorous science and to social justice, and we are dedicated to bringing discovery and hope to those who need it most.” Dr. Alpert also holds the Dorothy and Marty Silverman Chair in Psychiatry at Einstein.
Joining Dr. Alpert in speaking at PRIME’s new home were Gordon F. Tomaselli, M.D., the Marilyn and Stanley M. Katz Dean at Einstein and executive vice president and chief academic officer of Montefiore Medicine, and PRIME co-directors Vilma Gabbay, M.D., M.S., and Jelena Radulovic, M.D., Ph.D., both professors of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein. Dr. Radulovic is also the Sylvia and Robert S. Olnick Chair in Neuroscience.
Recent National Institutes of Health awards to PRIME and collaborating programs total more than $30 million. “This is just the beginning; we’re going to expand, and the journey has been very exciting,” said Dr. Gabbay, who is also a clinical psychiatrist at Montefiore.